TY - JOUR
T1 - Higher n-3 polyunsaturated fatty acid status during early pregnancy is associated with lower risk for depression at 12 months postpartum
T2 - The NuPED study
AU - Osuna, Ester
AU - Symington, Elizabeth A.
AU - Malan, Linda
AU - Ricci, Cristian
AU - Zandberg, Lizelle
AU - Smuts, Cornelius M.
AU - Baumgartner, Jeannine
N1 - Funding Information:
The NuPED study was supported in part by the National Research Foundation of South Africa, Unique Grant 99374 (EAS) (https://www.nrf.ac.za/) and the South African Medical Research Council under a Self-Initiated Research Grant (CMS) (http://www.mrc.ac.za/). The NuPED work has further received financial support from the University of South Africa’s Research Department through the Academic Qualification Improvement Programme (EAS) (www.unisa.ac.za). EO received a PhD fellowship from the Ebnet Foundation, Teufen, Switzerland.
Publisher Copyright:
© 2023 The Author(s)
PY - 2023/3
Y1 - 2023/3
N2 - Perinatal depression can negatively affect the health of the mother and her offspring. N-3 polyunsaturated fatty acids (PUFA) may play a role in the aetiology of depression. Therefore, we investigated the association of n-3 PUFA status during early pregnancy with perinatal depression among women living in urban Johannesburg, South Africa. For this prospective analysis, we analysed red blood cell (RBC) total phospholipid fatty acid (FA) composition (% of total FA) of 242 pregnant women at <18 weeks’ gestation. We used the Edinburgh Postnatal Depression Scale (EPDS) to identify women at risk for depression (EPDS score ≥9) at <18, 22 and 36 weeks’ gestation, and at 6 and 12 months postpartum. RBC EPA status was negatively (β=-0.22, p<0.05), and the AA/EPA ratio positively (β=0.24, p<0.05) associated with EPDS scores at 12 months postpartum. Higher RBC DHA and n-3 index were further associated with lower odds (OR=0.56 [95% CI: 0.32-0.91]; OR=0.63 [95% CI: 0.39-0.94]), while higher n-6/n-3 PUFA and AA/EPA ratios early in pregnancy were associated with higher odds for depression at 12 months postpartum ((OR=2.34 [95% CI: 1.12-4.97]; OR=1.02 [95% CI: 1.00-1.05]). Our results suggest that women with a higher RBC n-3 PUFA status during early pregnancy may be at lower risk for depression at 12 months postpartum.
AB - Perinatal depression can negatively affect the health of the mother and her offspring. N-3 polyunsaturated fatty acids (PUFA) may play a role in the aetiology of depression. Therefore, we investigated the association of n-3 PUFA status during early pregnancy with perinatal depression among women living in urban Johannesburg, South Africa. For this prospective analysis, we analysed red blood cell (RBC) total phospholipid fatty acid (FA) composition (% of total FA) of 242 pregnant women at <18 weeks’ gestation. We used the Edinburgh Postnatal Depression Scale (EPDS) to identify women at risk for depression (EPDS score ≥9) at <18, 22 and 36 weeks’ gestation, and at 6 and 12 months postpartum. RBC EPA status was negatively (β=-0.22, p<0.05), and the AA/EPA ratio positively (β=0.24, p<0.05) associated with EPDS scores at 12 months postpartum. Higher RBC DHA and n-3 index were further associated with lower odds (OR=0.56 [95% CI: 0.32-0.91]; OR=0.63 [95% CI: 0.39-0.94]), while higher n-6/n-3 PUFA and AA/EPA ratios early in pregnancy were associated with higher odds for depression at 12 months postpartum ((OR=2.34 [95% CI: 1.12-4.97]; OR=1.02 [95% CI: 1.00-1.05]). Our results suggest that women with a higher RBC n-3 PUFA status during early pregnancy may be at lower risk for depression at 12 months postpartum.
KW - AA/EPA ratio
KW - Edinburgh postnatal depression scale (EPDS)
KW - Fatty acid patterns
KW - Low- and middle-income countries (LMIC)
KW - n-3 Index
KW - n-3 polyunsaturated fatty acids
KW - n-6/n-3 ratio
KW - Perinatal depression
KW - Pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85147272336&partnerID=8YFLogxK
U2 - 10.1016/j.plefa.2022.102528
DO - 10.1016/j.plefa.2022.102528
M3 - Article
C2 - 36716632
AN - SCOPUS:85147272336
SN - 0952-3278
VL - 190
JO - Prostaglandins Leukotrienes and Essential Fatty Acids
JF - Prostaglandins Leukotrienes and Essential Fatty Acids
M1 - 102528
ER -